Canada Respiratory Devices Market Insights Forecasts to 2033

• The Market is growing at a CAGR of 8.5% from 2023 to 2033
• The Canada Respiratory Devices Market Size is expected to hold a significant share by 2033

The Canada Respiratory Devices Market is anticipated to hold a significant share by 2033, growing at a CAGR of 8.5% from 2023 to 2033. The increasing prevalence of respiratory disorders, technological advancements, and growing application in homecare settings are driving the growth of the respiratory devices market in the Canada.     

Market Overview

Respiratory devices refer to respiratory diagnostic devices, therapeutic devices, and breathing devices that provide long-term artificial respiration. They are intended to support breathing, remove carbon dioxide, and therapy to disuse atrophy of abdominal wall muscles. They might also contain a breathing machine that forces oxygen into an asphyxia victim's lungs to resuscitate them. Further, mechanical ventilators and secretion removal tools are used to support the pulmonary function of patients, especially those with neurological deficits. The market for respiratory care devices could expand as a result of the growing need for home care treatment equipment. The increasing use of point-of-care testing owing to the increased patient self-testing and the growing number of diagnostic tests for different conditions gives an improved level of accuracy of tests, are offers market opportunities for respiratory devices.

Report Coverage

This research report categorizes the market for the Canada respiratory devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada respiratory devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada respiratory devices market.

Driving Factors

About 3.8 million Canadians are suffering from asthma and 2.0 million are chronic obstructive pulmonary disease (COPD) suffering people. The increased prevalence of asthma and COPD among the people in Canada is driving the market demand for respiratory devices. The ongoing trend in respiratory care management including recent breakthroughs like intelligent respiratory monitoring systems, predictive analytics for respiratory diseases, and advanced ventilation technologies, are driving the market growth. Further, the rising use of home healthcare medical equipment including BiPAP, CPAP, ventilators, and oxygen concentrators for improving the quality of life for patients with respiratory issues is driving the market.   

Restraining Factors

The unfavorable reimbursement scenario and lack of patient compliance are challenging the Canada respiratory devices market.

Market Segmentation

The Canada Respiratory Devices Market share is classified into type, application, and end-user.

• The therapeutic devices segment dominated the market with a significant market share in 2023.

The Canada respiratory devices market is segmented by type into therapeutic devices, diagnostic & monitoring devices, and consumables & accessories. Among these, the therapeutic devices segment dominated the market with a significant market share in 2023. Therapeutic respiratory devices are used to manage respiratory diseases, providing relief and improve patient’s quality of life. It encompasses a wide range of tools such as inhalers, nebulizers, positive airway machines, and oxygen concentrators. The growing incidence of respiratory diseases and rapid technological advancements in devices are driving the market growth.

• The sleep apnea segment dominated the Canada respiratory devices market with a significant market share in 2023.       

Based on the application, the Canada respiratory devices market is divided into chronic obstructive pulmonary disease, sleep apnea, asthma, infectious diseases, and others. Among these, the sleep apnea segment dominated the Canada respiratory devices market with a significant market share in 2023. CPAP (continuous positive airway pressure) is a respiratory device prescribed by healthcare providers for treating sleep apnea. The increased prevalence of sleep apnea in elderly patients owing to factors like lack of awareness and non-specific symptoms are driving the market.

• The hospitals & ASCs segment dominated the Canada respiratory devices market in 2023.

Based on the end-user, the Canada respiratory devices market is divided into hospitals & ASCs, specialty clinics, home care settings, and others. Among these, the hospitals & ASCs segment dominated the Canada respiratory devices market in 2023. The advantages of using respiratory devices in hospitals and ASCs include consistent and quality respiratory care, quick therapy transitions, and easy use of noninvasive ventilation. The increasing demand for in-patient hospitalization for IV drug therapy and pulmonary rehabilitation for conditions like pneumonia and other conditions like COPD is driving the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Canada respiratory devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Koninklijke Philips N.V.
• Medtronic PLC
• Nihon Kohden Corporation
• Gentige AB
• Fisher & Paykel Healthcare Limited
• General Electronic Company (GE Healthcare)
• Dragerwerk AG & Co. KGaA
• Hamilton Medical AG
• Invacare Corporation
• Becton, Dickinson and Company
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In August 2024, Canadian device firm Trudell Medical announced that it had reached an agreement to purchase Vyaire Medical’s respiratory diagnostics (RDx) arm.

• In May 2023, Health Canada approved Vielight’s device to boost the recovery of Covid-19 patients using near-infrared light technology. The portable, lightweight, and non-invasive Vielight RX Plus device can be used without a prescription and is suitable for home and travel use.

• In May 2022, Honeywell announced two new NIOSH-certified respiratory offerings to help meet the needs of healthcare workers. The new products expand Honeywell’s personal protective equipment (PPE) portfolio for healthcare professionals, incorporating the company’s decades of expertise in producing respiratory-protection solutions.

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Canada Respiratory Devices Market based on the below-mentioned segments:

Canada Respiratory Devices Market, By Type

• Therapeutic Devices
• Diagnostic & Monitoring Devices
• Consumables & Accessories

Canada Respiratory Devices Market, By Application

• Chronic Obstructive Pulmonary Disease
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others

Canada Respiratory Devices Market, By End-User

• Hospitals & ASCs
• Specialty Clinics
• Home Care Settings
• Others